Introduction {#Sec1}
============

From the megalopolis to the individual level, the effects of air pollution are of particular interest. Urban air quality and indoor air pollution, which can lead to human health problems, are the most important topics occupying health authorities. According to the study of Jones ([@CR23]), indoor air is 5--10 times more polluted with volatile organic compounds (VOCs) than outdoor air. Bioaerosols are airborne particles that originate from living organisms including microorganisms. Different types of microorganisms have been identified as potential contaminants in indoor air, such as spores, bacterial cells and viruses (Douwes et al. [@CR9]). Indeed, in industrialized countries, people spend 90% of their time in enclosed or semi-enclosed spaces such as homes, offices, shopping centers, gymnasiums and transportation (Aritake et al. [@CR1]; Siegel [@CR35]; Turcotte [@CR38]; Klepeis et al. [@CR24]). Bioaerosols, more specifically viral aerosols, lead to diseases and represent a real challenge for the near future because of their high contagiousness. Viral aerosols can be transmitted by simple direct contact, droplets or aerosols. They can cause anything from an ordinary viral infection to an epidemic outbreak (Tellier [@CR37]).

Large numbers of buildings, particularly office buildings, use heating, ventilation and air-conditioning (HVAC) systems. These systems treat and transmit new air with temperature (*T*) and relative humidity (RH) regulation and a decrease in the particle concentration from the outside air (Seppänen and Fisk [@CR34]). Heating, cooling, humidification and filtration are the different steps performed by air handling units (AHUs) to recondition the air. AHUs should be well-maintained, contributing to good health and productivity. Filter efficiency is defined according to two main standards (EN779 [@CR12]; EN1822 [@CR11]), which describe medium-, high- and very high-efficiency filters. Filters are composed of fiber clusters (felts, mats, glass and papers), and their efficiency is characterized by four different mechanisms: sieving, inertia, interception and diffusion (Bailly [@CR2]).

In general, we expel by simply breathing, coughing, and sneezing (Morawska [@CR28]). Different studies have pointed out the number of viral particles exhaled during a single breath, sneeze or cough. For influenza viruses, an infected person can exhale 3--20 viruses per minute (Fabian et al. [@CR15]). A person infected with Coxsackievirus (a pathogenic enterovirus) can emit 160 viral particles when sneezing and coughing (Couch et al. [@CR6]; Downie et al. [@CR10]). The same studies showed that two infected people breathing in an office without sneezing or coughing could emit 20 viruses per minute, corresponding to 0.24 viruses per liter of air (without renewal of air in an office of 40 m^3^) (Couch et al. [@CR6]; Downie et al. [@CR10]). The results of the study by Miller et al. ([@CR27]) showed that fine particulate matter (PM) indoors in mechanically ventilated buildings comes from outside. The study of Zhao et al. ([@CR39]) evaluated 11 classifications of HVAC filters (MERV5 to HEPA) and ventilation systems located in 22 US cities and demonstrated that higher efficiency HVAC filters are likely to decrease premature mortality, increase life expectancy and yield monetary benefits in all of the homes and locations investigated herein. Some other studies have demonstrated that filters in the ventilation systems can be a source of microbial air pollution and that the ventilation systems and AHUs can spread and transport viral particles inside buildings (Ezratty and Squinazi [@CR13]; Fabian et al. [@CR14]; Tang et al. [@CR36]; Bluyssen et al. [@CR4]). Some recent studies have detected airborne viruses such as picornavirus, corona virus and parainfluenza virus on AHU filters (Myatt et al. [@CR30]; Goyal et al. [@CR21]; Prussin et al. [@CR31]). The persistence of the viral particles can be affected by the temperature and relative humidity (RH%) in the AHU. The persistence of influenza viruses increases with decreasing temperature and humidity (Lowen et al. [@CR26]). The review of Gerba ([@CR19]) revealed differences in inactivation between enveloped and non-enveloped respiratory viruses, with non-enveloped respiratory viruses surviving longer. The fate of mengovirus, a virus whose structure is close to rhinovirus, on the fiberglass filter of an AHU was studied by Bandaly et al. ([@CR3]), who showed that the mengovirus passed through the filter and remained infectious for up to 10 h up- and downstream of the system.

Concerning bioaerosols in AHUs, few studies have investigated the fate of viral aerosols on the filter. This work aimed to study the fate of adenovirus serotype 2 in an experimental setup representative of AHU. Adenovirus is a DNA human virus of the Adenoviridae family. This respiratory virus presents a spherical 70- and 90-nm-diameter particle (Doerfler [@CR8]) with an adenovirus infective dose equivalent to five viral particles for an adult responsible for pneumonia, angina and bronchitis (Musher [@CR29]). As we had already assessed the fate of mengovirus, a surrogate of a respiratory virus, we wanted to study the fate of a real respiratory virus in an AHU such as adenovirus. Therefore, the adenovirus behavior was explored up- and downstream of the fiberglass filter used in the AHU. The virus was characterized and quantified, and the analyses reviewed the performance of fibrous media in decreasing the risk of viral spread in a closed atmosphere and providing good indoor air quality and living conditions even with recycled indoor air.

Materials and methods {#Sec2}
=====================

Viral and cell models {#Sec3}
---------------------

Human adenovirus serotype 2 strain \[Health Protection Agency Culture Collections (HPACC); reference no. NCPV213\] was used throughout this study. Human embryonic kidney cells, type HEK-293, enabled the replication of adenovirus. HEK-293 cells were grown in Dulbecco's Modified Eagle\'s Medium (DMEM), high glucose, GlutaMAX™ Supplement (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% fetal calf serum (F2442, Sigma-Aldrich, St Louis, MO, USA), 1% non-essential amino acid (×100) (M7145, Sigma-Aldrich) and 1% antibiotic-antimycotic (×100) (A5955, Sigma Aldrich) at 37 °C under an atmosphere enriched with 5% CO~2~. The average initial concentration of the adenovirus in the suspension is up to 6 × 10^6^ TCID~50~.

Characteristics of the filter media {#Sec4}
-----------------------------------

The F7 filter (Camfil Farr, Stockholm, Sweden), in compliance with the EN 779 standard ([@CR12]), is a high-efficiency filter commonly used in AHUs and so was chosen for this study. It is made of fiberglass felt. The median fiber diameter is 1 ± 0.2 µm (González et al. [@CR20]). The nominal filtration velocity recommended by the manufacturer is 0.2 m s^−1^. The filter was implanted in flat geometry in this study with a filtration area of 17.72 cm^2^ (circular).

Experimental setup and validation (Fig. [1](#Fig1){ref-type="fig"}) {#Sec5}
-------------------------------------------------------------------

The experimental design consisted of a vertical column made of polymethyl methacrylate where the viruses were aerosolized and homogenized in the upward air flow. This aerosolization was carried out by the medical nebulizer (Omron C29-CompAir Pro, Hoofddorp, The Netherlands), which ensures an air flow of 4.5 l min^−1^ supplied by compressed air. At the upper side of the cylinder, four circular outputs of 4 cm diameter, which accommodate the filters, are arranged perpendicular to the flow. Three of the four outputs are equipped with the filter to be studied. The fourth output results were used to calculate the number of viruses that theoretically impacted on filters. Downstream of the filters, the BioSampler (SKC Inc., Eighty Four, PA, USA) samples the particles passing through the filters. The sampling rate is 13 l min^−1^ at the entry of each BioSampler. Two volumetric pumps are set downstream of the device to ensure the flow of treated air through the filters. The frontal filtration velocity at each filter is 0.16 m s^−1^ and is representative of the velocity observable in the AHUs on a pleated F7 filter. The device is positioned under a laminar flow hood with clean and sterile air (Fig. [1](#Fig1){ref-type="fig"}) (Bandaly et al. [@CR3]).Fig. 1Description of the experimental setup (Bandaly et al. [@CR3])

To monitor the number of generated particles and to determine the global setup performance at each of the four filter gates, a fluorescein (CAS no. 518-47-8, Merck KGaA, Darmstadt, Germany) solution was generated for 25 min by the medical nebulizer through the filter device, with or without a filter. The absorbance (*λ* = 470 nm) was measured in the sample from the BioSampler and the liquid extracted from the filters. According to Bandaly et al. ([@CR3]), the setup has an efficiency of 76.3% (0.58 mg fluorescein collected from an initial solution of 0.76 mg aerosolized).

While aerosolizing the medium without virus for 25 min, the temperature and RH% were measured in the setup at the filter level. The temperature remained stable at 16 °C ± 2 °C. The RH% increased to 80% after 3 min of aerosolization, reaching a maximum of 89% in 14 min. After 20 min, it decreased to 59% to achieve 52% after 25 min of aerosolization (Bandaly et al. [@CR3]).

Characteristics and efficiency of the BioSampler {#Sec6}
------------------------------------------------

The principle of the BioSampler (SKC Inc., Eighty Four, PA, USA) is to act as a particle collector. The respirable and non-respirable particles are separated by the curved inlet tube simulating the entry of air through the nasal passage. DMEM was the medium used to collect the particles from the air in the setup to put the viruses directly in the right conditions to be infective; 20 ml DMEM avoided liquid evaporation with a flow rate of 13 l min^−1^ for 15 min (Faure [@CR18]). The efficiency of the BioSampler changes according to the size of the particles: \> 50% for particles \> 0.03 µm, \> 80% for particles between 0.5 and 1 μm and \> 95% for particles \> 1 μm (Zheng and Yao [@CR40]). Samples of the collected liquid can be analyzed.

Preparation of the aerosolized virus suspension {#Sec7}
-----------------------------------------------

The fragility of the adenovirus was taken into consideration; the virus was obtained directly from the culture solution after multiplication in HEK-293. Centrifugation of the culture at 1750×*g* for 10 min removed cell debris. The supernatant was collected to be aerosolized.

### Aerosol characterization {#Sec8}

The Electrical Low Pressure Impactor (ELPI™, Dekati, Kangasala, Finland) and the Scanning Mobility Particle Sizer (SMPS™, GRIMM, Ainring, Germany) were used to analyze the aerosol size. These two instruments can characterize the aerosol size in different ways. The aerodynamic size of particles from 7 nm to 4 µm was characterized by the ELPI™, and the electrical mobility size of particles from 10 nm to 1 µm was characterized by the SMPS™. The special feature of ELPI™ is that the particles deposed on the various stages can be detected by molecular methods (Q-PCR). The SMPS™ samples are collected from the top and center of the column, and the ELPI™ samples are collected from the output without a filter.

Extraction, primers, probes and molecular assays {#Sec9}
------------------------------------------------

The NucliSens^®^ easyMAG™ Platform (Biomérieux, Marcy l'Etoile, France) was used to extract the adenovirus DNA. Adenovirus was quantified using a real-time SYBR green PCR carried out with the Brilliant III Ultra-Fast SYBR^®^ QPCR Mix kit (Agilent Technologies, Santa Clara, CA, USA) with the reverse primer AdF1B (5′-GGA-YGC-YTC-GGA-GTA-CCT-GAG-3′) and the forward primer AdR2B (5′-ACS-GTG-GGG-TTY-CTA-AAC-TTG-TT-3′) (Ryu et al. [@CR33]). The SYBR green Q-PCR program was as follows: 3 min at 95 °C for enzyme activation, 40 cycles of 20 s at 95 °C for denaturation and 20 s at 58 °C for annealing-extension. This was achieved on an Agilent MXPRO3005P PCR platform (Agilent Technologies). The DNA extract of adenovirus was used as the PCR-positive control. For this study, two PCR-negative controls were approved: the water used in the Brilliant III Ultra-Fast SYBR^®^ QPCR Mix and the DMEM used for culture. Adenovirus was quantified by the standard curve, based on the calibration of the virus initial solution. The melting curve was used as a quality control of the specificity of the method.

### Tissue culture infective dose test (TCID~50~) (determination of adenovirus infectivity) {#Sec10}

To determine the adenovirus infectivity up- and downstream of the system, the TCID~50~ test was used. It was carried out on HEK-293 cells seeded in 96-well plates, infected with serial dilutions of the sample and then incubated at 37 °C with 5% CO~2~ for 48 h. The positive wells in the plates, showing the apoptotic effect, were counted under a microscope. Using the Spearman-Karber statistical method, the infectivity of the virus was calculated (Ramakrishnan [@CR32]).

Extracting viruses from the tested F7 filter {#Sec11}
--------------------------------------------

The filters were washed in 20 ml preheated DMEM with stirring at 250 rpm for 30 min in two stages. After centrifugation, the supernatant was recovered and treated with chloroform. This step removes all contaminant microorganisms such as bacteria and fungi. The same extraction was carried out on a virgin filter to confirm that there was no adverse effect of the filter on the HEK-293 cells when using the TCID~50~ test. Adenovirus was quantified per genomic unit (GU) on a filter to test the loss of quantity by using this extraction method; from 3.24 × 10^5^ GU cm^−2^ of adenovirus theoretically deposited on the filter, 2.43 × 10^5^ GU cm^−2^ was detected by Real-Time PCR based on SYBR-Green. This indicates a loss of 0.12 log of virus, giving a yield of 75% for this extraction method.

Normalization results {#Sec12}
---------------------

The quantification and infectivity of the virus were normalized by the volume of air and the area of the filter.

For the initial solution, the results were normalized per cubic meter of air volume passed through the four outputs in the system, equal to 1.3 m^3^ of air during the 25 min of aerosolization. Each output related to the BioSampler represents 0.325 m^3^ of air volume passed during the 25 min of aerosolization.

For the adenovirus quantification or infectivity on the filters, the results were normalized by the filter area equal to 17.72 cm^2^.

To compare the quantification with the infectivity of the adenovirus, the result of infectivity (TCID~50~) should be converted to the plaque-forming unit (PFU) where 1 TCID~50~ is equal to 0.69 PFU.

Results {#Sec13}
=======

Characterization of adenovirus aerosol {#Sec14}
--------------------------------------

Figures [2](#Fig2){ref-type="fig"} and [3](#Fig3){ref-type="fig"} present the ELPI™ and SMPS™ particle size distribution measurement of the adenovirus suspension aerosolized by the medical nebulizer. The median aerodynamic size (*d*~ae.50~), calculated from the ELPI™ polydisperse particles is 110 nm (Fig. [2](#Fig2){ref-type="fig"}). The SMPS™ polydisperse particle size distribution measurement presents a median electric mobility size (*d*~ae.50~) of 87 nm (Fig. [3](#Fig3){ref-type="fig"}). The ELPI™ collected the particles at different stages, and these were extracted in DMEM. Detection and quantification of the virus were carried out by SYBR green Q-PCR. Based on the concentration of nebulized virus in the initial solution, the virus was quantified at the various stages. Different quantities of adenovirus were detected in all the collected fractions. The largest amount measured between 382 and 1600 nm, while the smallest quantity (negligible) was detected at the stages representing a size \< 56 nm (Fig. [4](#Fig4){ref-type="fig"}). The error deviation in the figures is based on 1100 samples (1 measure per second during an 18-min period).Fig. 2ELPI™ particle size distribution measurement of the adenovirus suspension aerosolized by the medical nebulizer \[d(N) = number of particles; dp = particle diameter\]. The error deviation in the figures is based on 1100 samples (1 measure per second during an 18-min period)Fig. 3SMPS™ particle size distribution measurement of the adenovirus suspension aerosolized by the medical nebulizer \[d(N) = number of particles; dp = particle diameter\]. The error deviation in the figures is based on 1100 samples (1 measure per second during an 18-min period)Fig. 4Adenovirus detection and quantification at each ELPI™ stage. The error deviation in the figures is based on 1100 samples (1 measure per second during an 18-min period) with two qPCR replicates

Detection and quantification of adenovirus upstream, downstream and on the filters in the experimental setup {#Sec15}
------------------------------------------------------------------------------------------------------------

Based on the SYBR^®^ QPCR measurement, the adenovirus recovered in the system (filters and BioSampler) and the total initial output aerosolized were measured. The F7 filter efficiency was calculated by comparing viruses recovered on the filter and adenovirus quantity downstream of the system in the absence of a filter. The filter F7 efficiency was between 91 and 99%. With reference to the study of the efficiency curves of the filtration carried out by González et al. ([@CR20]), the F7 showed efficiency between 80 and 90% for particle diameters equal to 0.4 µm, and it increased with particle diameters \< 0.4 µm. Comparing the present virus size, the experimental setup shows consistent filtration performance.

The average quantification of two experiments showed that from an initial solution of 3.99 × 10^6^ GU aerosolized for 25 min, 2.84 × 10^6^ GU of adenovirus was collected on the three filters, and 1.06 × 10^5^ GU passed through them. BioSampler no. 4, the output without a filter, collected 8.56 × 10^5^ GU (Table [1](#Tab1){ref-type="table"}). Comparing this quantity to the initial concentration aerosolized, there was a loss of 0.67 log of adenovirus in the system. The fluorescein validation carried out in the study of Bandaly et al. ([@CR3]) demonstrated that this loss is attributed to the non-recovered virus present on the column and the pipes. After 25 min of aerosolization, a few microliters of adenovirus remained in the medical nebulizer. Comparing the concentration of the initial solution and the rest of the Omron, no concentration effect was observed during aerosolization (data not shown).Table 1Average quantification and infectivity detection of the initial aerosolized viral suspension, samples from BioSamplers and the virus extracted from filters by SYBR^®^ QPCR measurement (GU) (quantification) and TCID measurement (infectivity detection) normalization of the virus detection by volume of air and area of the filterAverageQuantity (GU)Quantity (TCID~50~)Initial viral suspension3.99 × 10^6^5.94 × 10^6^Filter 17.91 × 10^5^2.18 × 10^3^Filter 29.9 × 10^5^1.61 × 10^3^Filter 31.06 × 10^6^2 × 10^3^BioSampler 14.31 × 10^4^1.33 × 10^2^BioSampler 22.67 × 10^4^1.84 × 10^2^BioSampler 33.65 × 10^4^1.94 × 10^2^BioSampler 48.56 × 10^5^2.27 × 10^5^

Adenovirus infectivity in the experimental setup (upstream, downstream and on the filters) {#Sec16}
------------------------------------------------------------------------------------------

The infectivity levels of adenovirus showed that 5.94 × 10^6^ TCID~50~ of infectious adenovirus was aerosolized upstream of the system, and 2.27 × 10^5^ TCID~50~ was collected downstream of the system in the absence of a filter; 1.41 log of adenovirus infectivity was lost during the aerosolization (Table [1](#Tab1){ref-type="table"}). This result demonstrates an effect of aerosolization on the virus infectivity. According to the TCID~50~ test, about 500 adenoviruses that passed downstream of the system remained infectious, and 5.79 × 10^3^ TCID~50~ was recovered on the total of filters 1, 2 and 3. The adenovirus left in the medical nebulizer after aerosolization remained infective. Comparing the remaining virus in the Omron with the initial solution aerosolized, no loss of infectivity of adenovirus was detected (data not shown).

Adenovirus infectivity versus quantification (Fig. [5](#Fig5){ref-type="fig"}) {#Sec17}
------------------------------------------------------------------------------

To compare the quantification and infectivity of adenovirus on filters or in the BioSampler, the adenovirus collected was quantified by PCR (GU), and infectivity was assessed using the plaque-forming unit (PFU) (1 TCID = 0.69 PFU). The determination of adenovirus infectivity is an estimate calculated using the Spearman-Karber statistical method.Fig. 5Infectivity and quantification comparison of adenovirus downstream of the system and on the filters (average of 2 experiments)

The quantification and infectivity of the virus were normalized by the volume of air and the area of the filter. The adenovirus infectivity and quantification were measured for the output without a filter and showed 2.63 × 10^3^ GU m^−3^ air, of which 1.01 × 10^3^ PFU m^−3^ was infectious. Therefore, 0.42 log of adenovirus lost infectivity during the 25 min of aerosolization. Comparing the adenovirus infectivity and quantification on the filters, 1.61 × 10^5^ GU cm^−2^ was detected, of which 4.74 × 10^2^ PFU cm^−2^ remained infectious; thus, 2.5 log of virus lost infectivity. In the BioSamplers, 3.3 × 10^5^ viruses were detected per cubic meter of air passed through the filters, of which 1.6 × 10^3^ viruses remained infectious.

Discussion {#Sec18}
==========

In recent years, there have been many developments in indoor air treatment and bioaerosol microbial ecology. These have led to adaptations of equipment resulting in benefits for human health. We used the same experimental setup as in the study of Bandaly et al. ([@CR3]), which represents a real-life model of an air-handling unit. The same filter commonly used in AHUs (F7-Camfil EN779:[@CR12]) was employed; a filtration velocity of 0.16 m s^−1^ was applied, and the efficiency of the filtration was between 91 and 99%. This effectiveness was verified in the study of Bailly ([@CR2]), which determined the air filter efficiency based on the four filtration phenomena curves. Adenovirus, a DNA respiratory virus measuring between 70 and 90 nm, was chosen (Doerfler [@CR8]). In this study, we carefully studied the molecular detection and infectivity up- and downstream of the filters and the dynamics and characteristics of the adenovirus in the system. The SMPS™ has a median electric mobility size (*d*~ae.50~) of 87 nm, close to the theoretical size of adenovirus described in the study of Doerfler ([@CR8]). According to the apoptotic phenomenon and the way in which adenovirus multiplies in the HEK-293 cell, we can propose some hypotheses about the virus aerosol. The particles detected by Q-PCR on the stages below the virus size may be DNA fragments because of the apoptosis effect that disrupted the cells (Green [@CR22]). These disruptions may lead to autodegradation of the cell such as DNA degradation, which affected the DNA virus used in our study (Green [@CR22]). The nebulized adenovirus could be aerosolized as a single virus or groups of viruses or could be associated with cell debris and proteins. This hypothesis corresponds to reality; the function of sneezing is to expel mucus containing irritants from the nasal cavity and microorganisms such as respiratory viruses (Cole and Cook [@CR5]).

Based on Q-PCR and TCID~50~ measurement for the quantification and detection of infectivity in the system, the study shows that adenovirus was stopped by the medium F7 filter, but some particles passed through the filters and remained infectious. A negligible loss of infectivity was detected, confirming the study of Davis et al. ([@CR7]) who showed that the maximum adenovirus survival occurred at a high relative humidity of up to 89%. This RH value was observed in this experimental setup during the 25 min of aerosolization. The examined literature shows the presence of viruses on the filters of air treatment plants by molecular detection without any notion of the infectivity and fate of these viruses. The study of Goyal et al. ([@CR21]) did not detect any infectious viruses in used ventilation filters from two large public buildings, but they were able to detect viruses by PCR, while Farnsworth et al. ([@CR16]) showed the difficulty of detecting the persistence of viruses in AHUs since most viruses present on AHU filters are deactivated within a day.

Comparing this work with the study of Bandaly et al. ([@CR3]), there are morphologic and physiologic differences between adenovirus and mengovirus. Morphologically, adenovirus is a DNA virus with a size between 70 and 90 nm (Doerfler [@CR8]), while mengovirus is an RNA virus with a smaller size between 22 and 30 nm (Faulkner et al. [@CR17]). The physiologic differences are based on their multiplication in the host cells and their virulence. Adenovirus shows an apoptotic effect in the host cells, whereas mengovirus multiplication has a cytopathic effect. These different types of multiplication lead to different ways of virus release, as shown by comparing this work with the study of Bandaly et al. ([@CR3]) in which the initial viral solution had a greater cytopathic effect with mengovirus being released more easily with the bursting of cells than adenovirus in apoptotic cells. The study of Knight ([@CR25]) and the review of Gerba ([@CR19]) focused on the inactivation rate between respiratory viruses and showed that adenovirus has a low inactivation rate (0.011 log~10~ h^−1^), whereas mengovirus, with a similar structure to rhinovirus, has a higher inactivation rate (0.25 log~10~ h^−1^). These values are validated by comparing this work with the study of Bandaly et al. ([@CR3]), as adenovirus was more persistent in the system after aerosolization with a loss of \< 1 log, but mengovirus showed a loss of 4 log of infectivity.

According to Musher's review ([@CR29]), the oral secretions of people infected with adenovirus contain up to 10^6^ viruses per milliliter, which is in the same value range as the initial solution used in this work. Musher ([@CR29]) revealed that an adenovirus infective dose is equivalent to five viral particles for an adult. In this study, adenovirus was normalized per cubic meter of air, showing that 3.3 × 10^5^ viruses m^−3^ passed through the filters and 1.6 × 10^3^ viruses m^−3^ remained infectious during 25 min of aerosolization. In reality, an AHU blows or extracts 15 m^3^ h^−1^ per occupant and, to recover energy, in many office buildings up to 20% of the indoor air flow can be recycled. This concentration may spread the adenovirus back into the room and could infect the people present.

The major limitation of this study is that we used adenovirus from a cell culture, which is not representative of adenovirus that has been expelled from infected people, so one can suppose that the latter should be more persistent in AHUs. This has to be taken into account in studies of air recycling with the aim of economizing energy inside buildings.

Conclusion {#Sec19}
==========

Recent studies have tried to understand the gaps between the behavior of bacteria and fungi on filter media and the role of AHUs in the spread and transport of viral particles inside buildings. This study presents new information on the characterization and the behavior, etc., of adenovirus, a non-enveloped DNA respiratory virus, in indoor environments and its behavior in air treatment units. However, the evolution of air quality requirements (lack of biologic and hygienic quality) may lead to rethinking the principle of air recycling. These results are of major concern from a public health point of view, and policy makers have to take them into account to better protect public and human health.
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